Yüklüyor......

Design of a MUC1-based tricomponent vaccine adjuvanted with FSL-1 for cancer immunotherapy

MUC1 is an attractive target for cancer vaccines as a result of its over-expression and aberrant glycosylation pattern on many tumor cells. However, the low immunogenicity of MUC1 and immune tolerance have limited its application. Herein, we designed MUC1-based tricomponent antitumor vaccines adjuva...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medchemcomm
Asıl Yazarlar: Li, Mingjing, Wang, Zhaoyu, Yan, Bocheng, Yin, Xiaona, Zhao, Yue, Yu, Fan, Meng, Meng, Liu, Yonghui, Zhao, Wei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Royal Society of Chemistry 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6991171/
https://ncbi.nlm.nih.gov/pubmed/32133105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c9md00254e
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!